REDHILL BIOPHARMA LTD. Issued Capital
REDHILL BIOPHARMA LTD. (RDHL) had Issued Capital of $63.40 million as of 2025-06-30, per its 6-K filed 2025-09-05.
Financial Statements › Notes
ifrs-full:IssuedCapital · last filed 2025-09-05
- 2025-06-30: Issued Capital $63.40M.
- 2024-12-31: Issued Capital $35.04M.
- 2024-06-30: Issued Capital $34.78M.
- 2023-12-31: Issued Capital $21.44M.
| Period end | Issued Capital |
|---|---|
| 2025-06-30 | $63.40M 6-K · filed 2025-09-05 |
| 2024-12-31 | $35.04M 6-K · filed 2025-09-05 |
| 2024-06-30 | $34.78M 6-K · filed 2024-08-29 |
| 2023-12-31 | $21.44M 20-F · filed 2025-04-10 |
| 2023-06-30 | $4.62M 6-K · filed 2023-08-17 |
| 2022-12-31 | $2.83M 20-F · filed 2024-04-08 |
| 2022-06-30 | $1.83M 6-K · filed 2022-11-07 |
| 2021-12-31 | $1.50M 20-F · filed 2023-04-28 |
| 2021-06-30 | $1.31M 6-K · filed 2021-08-26 |
| 2020-12-31 | $1.05M 20-F · filed 2022-03-17 |
| 2020-06-30 | $986.00K 6-K · filed 2020-08-13 |
| 2019-12-31 | $962.00K 20-F · filed 2021-03-18 |
| 2019-06-30 | $767.00K 6-K · filed 2019-07-23 |
| 2018-12-31 | $767.00K 20-F · filed 2020-03-04 |
| 2018-06-30 | $577.00K 6-K · filed 2018-08-30 |
| 2017-12-31 | $575.00K 20-F · filed 2019-02-26 |
| 2016-12-31 | $441.00K 20-F · filed 2018-02-22 |